X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Telmisartan is a sartan (AT1 receptor blocker) and lowers blood pressure by blocking the effect of the messenger angiotensin II. It has the longest duration of action in its group and therefore also covers the early morning hours, when blood pressure rises most sharply. Alongside lowering blood pressure it protects the kidneys, particularly in type 2 diabetes with protein in the urine.
See more detail.gif)
Reminder, intake history and blood pressure readings in one place — free in the brite app.
| Property | Details |
|---|---|
| Active substance | Telmisartan |
| ATC code | C09CA07 |
| Substance class | AT1 receptor blocker (“sartan”, angiotensin II receptor antagonist) |
| Available forms | Tablets, usually 20 mg, 40 mg and 80 mg; in addition fixed combinations with hydrochlorothiazide or amlodipine |
| Half-life | Around 24 hours — the longest value within the sartans |
| Maximum daily dose | 80 mg according to the Summary of Product Characteristics; your individual dose is set by your doctor |
| Onset of action | A first drop in blood pressure within hours, the full effect usually only after four to eight weeks |
| Elimination | Almost entirely through the bile and the stool, hardly at all through the kidneys; practically without any involvement of the CYP enzymes |
| Prescription status | Prescription-only in Germany |
| Special feature | Thanks to its long duration of action it also covers the early morning hours; no typical dry cough as seen with ACE inhibitors |
Your body regulates blood pressure and its salt and water balance through the renin-angiotensin-aldosterone system. The decisive messenger in it is angiotensin II: it narrows the blood vessels and, through the hormone aldosterone, makes the kidneys hold on to sodium and water. Both push blood pressure up.¹
Telmisartan occupies the docking site for this messenger, the AT1 receptor. The vessels stay wider, the kidneys excrete more sodium, blood pressure falls. Because the receptor is blocked rather than — as with an ACE inhibitor — the formation of angiotensin II, telmisartan acts at a later point in the same chain.
Telmisartan is highly fat-soluble, which means it distributes well into the tissues, binds firmly to the receptor and only releases it slowly. The result is a half-life of around 24 hours — considerably longer than with most other sartans. In practice that means the effect is still comparatively stable shortly before the next tablet is due. For many people the early morning hours fall into exactly that window, the time when blood pressure naturally rises most sharply.¹
Three things follow directly from this mechanism and shape everyday life on telmisartan:
The following describes what the Summary of Product Characteristics sets out as the usual approach. It is not a recommendation on how to take it — your dose is set by your doctor and adjusted from there.
Telmisartan is uncomplicated in everyday life. The most important points, in the order of their practical weight:
So that at your next appointment it is clear what actually worked.
Telmisartan is considered comparatively well tolerated; most complaints occur while the dose is being adjusted and then ease off again.
Hardly any question about blood pressure medicines is asked as often — and hardly any is answered in such a muddled way. The honest short version: for most people the time of day matters less than regularity.
Blood pressure follows a daily rhythm: in most people it falls at night and rises markedly again in the early morning hours. Because heart attacks and strokes cluster in exactly that window, it seemed an obvious idea to give blood pressure medicines in the evening. A large Spanish study appeared to confirm this impressively — but after heavy methodological criticism it was retracted and can no longer be used as an argument. An independent British study on the timing of doses then found no difference between taking them in the morning and in the evening, as far as heart attacks, strokes and deaths are concerned. A general recommendation for evening dosing cannot be derived from this.¹,²
This is where the long duration of action pays off: because the concentration stays comparatively even over 24 hours, the morning gap is smaller from the outset than with short-acting substances. The question of “morning or evening” loses some of its sting as a result. Sometimes your practice will choose evening dosing deliberately — for example when 24-hour monitoring shows that blood pressure does not fall at night. That is an individual decision based on a measurement, not a general rule.
In practice that means: choose the time of day you can keep up in the long run — ideally tied to an existing habit. Do not change it every few weeks because something different is being recommended online.
Telmisartan is barely broken down by the CYP enzymes of the liver — the classic metabolic conflict with other tablets therefore plays a smaller role. Almost all of the relevant interactions come down to two questions: what happens to potassium? And what happens to blood flow through the kidneys?
| Combination | Consequence | What to do |
|---|---|---|
| NSAIDs (e.g. ibuprofen, diclofenac, naproxen) | The blood-pressure-lowering effect is weakened, kidney function can suffer | Only short term and after checking first; discuss alternatives such as paracetamol or metamizole |
| A sartan plus an NSAID plus a diuretic at the same time | Clearly increased risk of acute kidney failure — the so-called triple whammy | Have this three-way combination checked specifically by your doctor or pharmacist, especially in hot weather and during infections |
| Potassium-sparing diuretics such as spironolactone, potassium supplements, potassium-based salt substitutes | Potassium can rise to dangerous levels | Only with monitoring of the potassium value; avoid potassium-based salt substitutes |
| Lithium | Lithium levels can rise | Close monitoring of blood levels |
| An ACE inhibitor such as ramipril or aliskiren in addition | More kidney problems and more rises in potassium without additional benefit | Dual blockade is as a rule deliberately avoided |
| Alcohol | Stronger fall in blood pressure, more dizziness | Be cautious, especially while the dose is being adjusted |
The practically most important combination is the one in the second row — and it almost always comes about by accident. A sartan lowers the pressure inside the filtering units of the kidney. A diuretic such as furosemide additionally reduces the volume of fluid. If a painkiller from the NSAID group is added, it narrows the vessels leading into the kidney. All three effects together can push filtration down so far that acute kidney failure results — particularly during a stomach bug, a heatwave or a spell of drinking too little.
The catch: NSAIDs are available without a prescription and are not perceived by many people as “real” medicines. That is exactly why this combination rarely shows up on medication lists. Check it in the guide drug interactions or directly in the interaction check of the brite app. What generally applies with impaired kidney or liver function is covered under medications with kidney and liver disease.
The sentence that gets you somewhere at the pharmacy counter: “I take a sartan and a diuretic — does this painkiller fit with that?” On the subject of alcohol, see medications and alcohol.
In type 2 diabetes with early kidney damage, a sartan or an ACE inhibitor is part of standard treatment, because both slow the loss of protein into the urine and can slow the progression of kidney weakness.³
The usual pattern is baseline values before starting, a check in the first weeks and after every dose increase, plus regular checks as treatment goes on — and additional ones when there is a reason: diarrhoea, vomiting, fever, a heatwave or new painkiller treatment. How to make sense of your results is explained in the guide understanding blood values; on kidney disease itself there is the article chronic kidney disease.
All sartans work through the same mechanism. The differences lie mainly in how long they act, in their approved indications and in a few practical details.⁴
| Active substance | Special feature | Practically relevant |
|---|---|---|
| Telmisartan | Longest duration of action in the group, eliminated through the bile | Good 24-hour cover; not suitable in severe liver impairment |
| Candesartan | Also a long duration of action, very fine dose steps | Frequently used in high blood pressure and in heart failure |
| Valsartan | Broad evidence base after a heart attack and in heart failure | Also available in combination with sacubitril |
| Losartan | Shortest duration of action, lowers uric acid slightly | An argument with gout; the 24-hour cover is weaker |
The classic reason to switch from an ACE inhibitor such as ramipril or enalapril to a sartan is a persistent dry cough. This cough is not a cold: dry, tickly, often worse at night — and it does not go away as long as the ACE inhibitor is being taken. The cause is the messenger bradykinin, which builds up on ACE inhibitors and irritates the cough receptors. Telmisartan acts at a different point and, according to current evidence, does not trigger this effect.¹
Two things often come as a surprise when switching. The cough can linger for days or a few weeks after the ACE inhibitor is stopped — that does not mean the switch has failed. And the requirements for potassium and kidney monitoring stay exactly the same; a sartan is not a “gentler” medicine. As a rule the two groups are not combined with each other.
In high blood pressure, sartans and ACE inhibitors are comparable in their blood-pressure-lowering effect. For people at high cardiovascular risk or with coronary heart disease, telmisartan additionally holds an authorisation for the prevention of cardiovascular events. Which substance fits in an individual case is decided by your doctor on the basis of accompanying conditions such as heart failure, kidney values and how well it is tolerated.
While breastfeeding telmisartan is not recommended; there are better studied alternatives for that.
In older age treatment usually starts lower and is increased more slowly, because drops in blood pressure raise the risk of falls. One advantage of the long duration of action: it stays at one tablet a day. If you take several medicines at once, you will find orientation under medications in old age and polypharmacy.
With impaired kidney function telmisartan is not forbidden — on the contrary, it is frequently used precisely then. Because it is hardly excreted through the kidneys, a dose adjustment is usually not needed; it does, however, require closer monitoring of potassium and eGFR. If both renal arteries are narrowed, it is not suitable.⁶
With liver disease caution is needed, because telmisartan is eliminated through the bile. In severe liver impairment or obstruction of the bile ducts it must not be used according to the Summary of Product Characteristics; in mild to moderate impairment the dose is capped.
High blood pressure usually does not hurt, and so treating it feels like nothing at all. That is normal and no sign that the medicine is not working. The only reliable evidence is measured readings over several weeks — always at the same time of day, at rest. A record you can show at your appointment is worth more than the feeling of individual days. Approaches through lifestyle can be found under lowering blood pressure naturally.
Because of the half-life of around 24 hours, a single missed dose is less dramatic than with short-acting blood pressure medicines: the next day a relevant part of the substance is still in the body. But that is exactly what tempts people to let it slide more often. Anyone who regularly forgets two or three tablets a week is effectively on a lower dose — and is then puzzled by rising readings. Taking double the amount the next day is not a solution.
Good readings are the result of the treatment. If it ends, blood pressure rises again — usually not abruptly but over weeks, which obscures the connection. Reducing the dose is possible in some situations, after significant weight loss for example. That decision belongs to your doctor: stopping medications.
With fixed combinations the amount of telmisartan frequently stays the same; two substances at a low dose often work better than one at the maximum dose. The only important thing is that you do not accidentally carry on taking the old single tablet as well (generics vs. brand-name medicines). And yes: exercise is part of the treatment — but in heat and with heavy sweating, blood pressure medicines make dizziness more likely (medications and exercise).
The interaction check shows critical combinations before you take them.
Reminder, blood pressure history and interaction check in one place. Free.
Create medication plan